Another potent AHR agonist IPyA has exhibited remarkable anti-inflammatory effects in experimental colitis models through raised colonic IL10-positive T cells and lessening the pro-inflammatory Th1 cytokines (Aoki et al., 2018). Here, AHR is linked to colitis.